# Novocardio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novocardio

- Industry: Biotechnology
- Headquarters: Beijing, China
- Latest round: Angel (Feb 8, 2018)
- Investors on record: 1

## About

Established in 2016 and based in Beijing, China, Novocardio is a biotechnology developer of gene sequencing, providing genetic testing services for cardiovascular diseases. In January 2020, the firm closed a pre-series A funding.

The company's main business is to provide clinical testing and scientific research collaboration services for cardiovascular diseases. Its business is applied in the fields of medical treatment, microbiology, animal and plant research and modern agricultural breeding.

The company’s revenue is generated by providing cardiovascular disease clinical testing and scientific research collaboration services.

## Funding rounds

- Angel, Feb 8, 2018 — CASH Capital

## Investors

- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Angel